Valuation: Sysmex Corporation

Market Cap 1,125B 7.17B 6.25B 5.9B 5.36B 10.04B 688B 10.09B 70.71B 27.29B 350B 26.93B 26.33B P/E 2027 *
28.2x
P/E 2028 * 22.8x
Enterprise Value 1,148B 7.31B 6.38B 6.02B 5.47B 10.24B 702B 10.29B 72.11B 27.83B 357B 27.47B 26.86B EV / Sales 2027 *
2.11x
EV / Sales 2028 * 2x
Free-Float
72.3%
Yield 2027 *
2.18%
Yield 2028 * 2.24%
1 day+1.09%
1 week+1.09%
Current month-2.11%
1 month+15.77%
3 months+36.05%
6 months+42.76%
Current year+21.92%
1 week 12.04
Extreme 12.04
12.04
1 month 11.91
Extreme 11.91
12.5
Current year 7.97
Extreme 7.97
12.5
1 year 7.97
Extreme 7.97
12.5
3 years 7.97
Extreme 7.97
20.72
5 years 7.97
Extreme 7.97
45.23
10 years 7.97
Extreme 7.97
45.45
Manager TitleAgeSince
Chief Executive Officer 77 2018-03-31
Director of Finance/CFO 56 -
President 65 2026-03-31
Director TitleAgeSince
Chairman 77 2013-03-31
Director/Board Member 65 2019-05-31
Director/Board Member 71 2019-05-31
Change 5-day change 1-year change 3-year change Capi.($)
+1.09%+1.09% - - 7.28B
+0.37%+0.65%-23.75%+1.59% 177B
-0.69%+1.29%-3.62%+11.27% 119B
-0.20%-3.98%+6.17%+72.47% 59.04B
-0.24%+1.74%-3.94%-31.61% 49.41B
-0.22%-0.37%+7.26%+35.20% 48.64B
+1.61%+7.61%+17.91%-6.24% 33.18B
-1.49%-2.74% - - 28.18B
-1.17%+4.64%+42.09%-8.18% 25.8B
+1.02%+5.99%+7.20%-19.54% 21.91B
Average +0.01%+1.66%+6.16%+6.87% 62.41B
Weighted average by Cap. -0.07%+0.88%-4.26%+9.75%

Financials

2027 *2028 *
Net sales 545B 3.47B 3.03B 2.86B 2.59B 4.86B 333B 4.88B 34.22B 13.21B 169B 13.04B 12.75B 574B 3.66B 3.19B 3.01B 2.73B 5.12B 351B 5.14B 36.06B 13.91B 178B 13.73B 13.43B
Net income 40.77B 260M 227M 214M 194M 364M 24.92B 365M 2.56B 989M 12.67B 976M 954M 49.7B 317M 276M 261M 237M 443M 30.38B 445M 3.12B 1.2B 15.44B 1.19B 1.16B
Net Debt 22.37B 143M 124M 117M 107M 200M 13.67B 200M 1.41B 542M 6.95B 535M 523M 21.54B 137M 120M 113M 103M 192M 13.17B 193M 1.35B 522M 6.7B 516M 504M
Logo Sysmex Corporation
SYSMEX CORPORATION is a Japan-based company engaged in the development, manufacture, sale, servicing and import/export of clinical testing instruments and reagents for the medical field. It proposes solutions to address the diverse challenges faced by medical institutions by integrating a wide range of products and services, including software, maintenance for clinical testing equipment, and academic support. It operates business through four segments centered on regional controlling entity, including Headquarters, Americas, Europe, Middle East and Africa (EMEA), China and Asia-Pacific (AP). Headquarters segment operates with the Company itself acting as the controlling entity, responsible for product development, manufacture and others, consolidated subsidiaries within this segment handle the development and manufacturing of certain products, as well as domestic and overseas sales. Americas, Europe, EMEA, China and AP segments operate business in their respective regions.
Employees
10,861
Date Price Change Volume
26-09-18 US$12.04 +1.09% 1,665
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
1,859.50JPY
Average target price
2,067.86JPY
Spread / Average Target
+11.21%

Quarterly revenue - Rate of surprise

LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!